The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 226K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kengatharan, K. M.
Right arrow Articles by Thiemermann, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kengatharan, K. M.
Right arrow Articles by Thiemermann, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1998/7/305/ $5.00
The Journal of Experimental Medicine, Volume 188, Number 2, July 20, 1998 305-315


Articles

Mechanism of Gram-positive Shock: Identification of Peptidoglycan and Lipoteichoic Acid Moieties Essential in the Induction of Nitric Oxide Synthase, Shock, and Multiple Organ Failure

Ken M. Kengatharan*, Sjef De Kimpe{ddagger}, Caroline Robson*, Simon J. Foster§, and Christoph Thiemermann*

From the * William Harvey Research Institute, St. Bartholomew's and the Royal London School of Medicine and Dentistry, London EC1M 6BQ, United Kingdom; the {ddagger} Department of Pharmacology and Pathophysiology, Utrecht Institute for Pharmaceutical Science, Utrecht University, 3584 CA Utrecht, The Netherlands; and the § Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield S10 2TN, United Kingdom

The incidence of septic shock caused by gram-positive bacteria has risen markedly in the last few years. It is largely unclear how gram-positive bacteria (which do not contain endotoxin) cause shock and multiple organ failure. We have discovered recently that two cell wall fragments of the pathogenic gram-positive bacterium Staphylococcus aureus, lipoteichoic acid (LTA) and peptidoglycan (PepG), synergize to cause the induction of nitric oxide (NO) formation, shock, and organ injury in the rat. We report here that a specific fragment of PepG, N-acetylglucosamine-β-[1-> 4]-N-acetylmuramyl-L-alanine–D-isoglutamine, is the moiety within the PepG polymer responsible for the synergism with LTA (or the cytokine interferon {gamma}) to induce NO formation in the murine macrophage cell line J774.2. However, this moiety is also present in the PepG of the nonpathogenic bacterium Bacillus subtilis. We have discovered subsequently that S. aureus LTA synergizes with PepG from either bacterium to cause enhanced NO formation, shock, and organ injury in the rat, whereas the LTA from B. subtilis does not synergize with PepG of either bacterium. Thus, we propose that the structure of LTA determines the ability of a particular bacterium to cause shock and multiple organ failure (pathogenicity), while PepG acts to amplify any response induced by LTA.

Key Words: gram-positive shock • nitric oxide • peptidoglycan • lipoteichoic acid


Address correspondence to Chris Thiemermann, The William Harvey Research Institute, St. Bartholomew's and the Royal London School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK. Phone: 44-171-982-6025; Fax: 44-171-251-1685; E-mail: c.thiemermann{at}mds.qmw.ac.uk

C. Thiemermann is a Senior Fellow of the British Heart Foundation (FS 016/96). S.J. Foster is supported by the Royal Society. This work was supported by a Biomed II grant of the European Commission.

Abbreviations used: AE-ITU, aminoethyl-isothiourea; ALT, alanine aminotransferase; D- or L-ala, D- or L-alanine; iNOS, inducible NOS; L-lys, L-lysine; L-NMMA, NG-methyl-L-arginine; LTA, lipoteichoic acid; MTT, 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide; NAG, N-acetylglucosamine; NAM, N-acetylmuramic acid; NAG-NAM-L-ala- D-isoglutamine, N-acetylglucosamine-β-[1-> 4]-N-acetylmuramyl-L-alanine- D-isoglutamine; NO, nitric oxide; NOS, NO synthase; PepG, peptidoglycan; RASMC, rat aortic smooth muscle cell(s); SALE, Staphylococcus aureus lytic enzyme.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS